GLP-1 medications
Semaglutide Blood Test UK: What to Monitor
Reviewed by a qualified clinician · analysed at UKAS-accredited UK labs (ISO 15189)
Last reviewed June 202614 min read
Every Helvy guide is written by our health editors, then checked by a qualified clinician before it goes live and re-checked as the science moves. We name clinical roles, not individuals, until each reviewer has agreed to be credited publicly. This is wellness guidance to help you understand your own data, not a diagnosis.
QUICK ANSWER
Semaglutide is the molecule behind Ozempic, Wegovy and Rybelsus. The markers most worth monitoring before and during treatment are thyroid (TSH), liver function, kidney function (creatinine and eGFR), HbA1c, a full lipid profile, and nutrients such as ferritin, B12, folate and vitamin D. A baseline first, a recheck around three months in, then roughly every six months. Always discuss results with your prescriber or GP.
Semaglutide is one of the most prescribed medicines of the decade. The same molecule is sold under different names for different uses, which is a frequent source of confusion. The STEP 1 trial reported average weight loss of about 15 percent, and the SELECT trial showed a 20 percent reduction in major cardiovascular events. Changes of that scale are worth keeping an eye on with a few well-chosen blood markers.
This guide explains which markers matter, what their ranges mean in plain English, and how often testing is reasonable, whichever brand of semaglutide you are on. It is informational only and contains no dosing advice or diagnosis.
1. What is semaglutide, and which brands use it?
Semaglutide is a GLP-1 receptor agonist, a medicine that mimics a natural gut hormone to reduce appetite and help regulate blood sugar. It is the active ingredient in three products you may have heard of:
- Ozempic, a weekly injection licensed for type 2 diabetes.
- Wegovy, a weekly injection licensed for weight management at a higher dose.
- Rybelsus, a daily tablet form licensed for type 2 diabetes.
Because the molecule is the same, the monitoring logic is the same regardless of brand. If you specifically want the brand-by-brand view, see our Ozempic guide and Wegovy guide. Tirzepatide (Mounjaro) is a different, dual-action molecule covered in our Mounjaro guide.
2. Why monitor blood markers on semaglutide?
Semaglutide changes far more than appetite. Rapid weight loss affects liver enzymes, kidney function, nutritional status, hormones and body composition. The NICE guideline on obesity management recommends monitoring HbA1c, lipid profiles and blood pressure during pharmacological weight treatment, and that is a sensible minimum.
If you want to understand how the medicine is affecting your body rather than only whether you are losing weight, a broader set of markers gives the fuller picture. The point of testing is not to self-diagnose, but to give you and your clinician objective data to work from.
3. Markers worth a baseline before you start
A baseline before your first dose is the most useful test you will do, because every later result is read against it. A sensible baseline covers:
- Thyroid (TSH, ideally with Free T4 and Free T3)
- Liver function (ALT, ALP, albumin)
- Kidney function (urea, creatinine, eGFR)
- HbA1c and, where available, fasting glucose
- Full lipid profile (total, LDL, HDL, triglycerides, non-HDL)
- Ferritin and iron, vitamin D, B12 and folate
- Full blood count
Our Thyroid & Vital Organs panel covers thyroid (TSH, Free T4, Free T3), liver, kidney and a full cholesterol profile from a home finger-prick sample. HbA1c and the nutrients sit in other panels or can be arranged through your GP, so combine the testing that matches your situation.
4. Thyroid: the safety check
Semaglutide carries a boxed warning about thyroid C-cell tumours seen in rodent studies. The relevance to humans is uncertain, but it is why the medicine is not used in people with a personal or family history of medullary thyroid cancer or Multiple Endocrine Neoplasia type 2. Weight loss itself can also shift thyroid function as your metabolic rate adjusts.
A TSH test is the standard screen, usually reported against roughly 0.4 to 4.0 mIU/L. New neck swelling, a persistent hoarse voice or trouble swallowing should be reviewed promptly rather than tracked at home. Our thyroid blood test guide explains the full panel.
5. Liver and kidney function
As stored fat is mobilised during rapid weight loss, it is processed through the liver, which can nudge enzymes such as ALT upward for a time. In most people the longer-term trend improves. A sustained climb is a flag to raise with your prescriber rather than interpret alone.
On the kidney side, nausea and reduced fluid intake during dose increases are the main reason creatinine and eGFR can dip. An eGFR above 90 is generally normal, 60 to 89 suggests mild reduction worth watching, and a sudden fall of more than about a quarter from baseline is a reason to seek advice. Our kidney function guide covers each marker.
6. HbA1c and lipids: tracking real progress
The metabolic improvements are the part that reduces long-term risk. HbA1c reflects your average blood sugar over two to three months. Below 42 mmol/mol is in the normal range, 42 to 47 sits in the prediabetes band, and 48 or above is the diabetes range. Semaglutide was first developed as a diabetes treatment, so improvement here is often clear.
Weight loss usually improves lipids too: lower LDL and triglycerides, often higher HDL. If weight is falling but lipids are not, it can point to a genetic driver worth discussing. Our cholesterol guide sets out the ranges.
7. Nutrients: the cost of a smaller appetite
Semaglutide suppresses appetite and slows gastric emptying, so many people eat considerably less. Fewer calories means fewer vitamins and minerals, and over months that can show up as fatigue, hair thinning and poor recovery. Worth watching are ferritin, vitamin D, vitamin B12 and folate.
Ferritin below about 30 micrograms per litre is linked to fatigue even with a normal haemoglobin, and vitamin D below 25 nmol/L is in the deficient range in UK terms. If you take metformin alongside semaglutide, keep a closer eye on B12, since metformin can lower it over time. Agree any supplementation with a clinician rather than guessing.
8. Oral semaglutide and compounded versions
Oral semaglutide (Rybelsus) works through the same receptor as the injectable form, so the monitoring markers are the same. Absorption is more sensitive to timing and food, which is a dosing matter for your prescriber rather than something a blood test resolves.
Compounded semaglutide, made by compounding pharmacies rather than the licensed manufacturer, works through the same mechanism and carries the same monitoring needs. The MHRA advises using only licensed medicines from regulated pharmacies.
9. A sensible testing schedule
| Marker group | Baseline | 3 months | Ongoing |
|---|---|---|---|
| Thyroid (TSH) | Yes | Optional | Every 6 months |
| Liver and kidney | Yes | Yes | Every 6 months |
| HbA1c and lipids | Yes | Yes | Every 6 months |
| Ferritin, D, B12, folate | Yes | Yes | Every 6 months |
Most people retest once they reach their maintenance dose, since the titration weeks give a less stable picture. Your prescriber may suggest a different rhythm.
10. Frequently asked questions
Is semaglutide the same as Ozempic and Wegovy?+
Yes. Semaglutide is the active molecule in Ozempic (for type 2 diabetes), Wegovy (for weight management at a higher dose) and Rybelsus (a daily tablet). Because the molecule is the same, the blood markers worth monitoring are the same across all three.
Does semaglutide show up on a blood test?+
No. Standard blood tests do not detect semaglutide and it does not appear on routine panels or drug screens. What is visible are its effects, such as a falling HbA1c, improving lipids and shifts in liver enzymes.
What blood tests should I get before starting semaglutide?+
A useful baseline covers thyroid (TSH), liver function, kidney function (creatinine and eGFR), HbA1c, a full lipid profile and nutrients such as ferritin, vitamin D, B12 and folate, plus a full blood count. Your prescriber can advise on what fits your history.
How often should I test on semaglutide?+
A common pattern is a baseline before starting, a recheck around three months in once you have reached your maintenance dose, then roughly every six months. Your clinician may suggest a different schedule.
Do the markers differ for oral semaglutide (Rybelsus)?+
No. Oral and injectable semaglutide work through the same receptor, so the monitoring markers are identical. Absorption timing differs, but that is a dosing matter for your prescriber rather than something a blood test resolves.
Do I need to fast before a semaglutide monitoring blood test?+
For lipids and glucose-related markers, a fast of 10 to 12 hours (water is fine) gives the most accurate result. Thyroid, HbA1c and nutritional markers are not greatly affected by fasting, but one fasted sample is simplest.
Medical disclaimer: This content is for information only and is not medical advice, diagnosis or treatment. Semaglutide is a prescription medicine. Always follow the guidance of your prescriber, and do not start, stop or change a dose based on this article. All Helvy blood tests are processed at UKAS-accredited UK laboratories to ISO 15189.
Last updated: June 2026 · By Helvy
Test for this
Keep reading